Tackling immunomonitoring in gastrointestinal cancer

Current Opinion in Oncology
Maëlle AnciauxAlain Hendlisz

Abstract

The growing awareness that the immune system is a key player in the antitumoral response and the excellent clinical results achieved in some settings with anti-programmed cell death 1 (PD1)/programmed death ligand 1 (PDL1) and anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA4) drugs has led to the rise of immunotherapy as a supplement or an alternative to conventional cancer treatment. The high costs associated with these therapies, their significant toxicity and the need to understand and circumvent immune escape mechanisms raise the urgent need for immunological assessment of therapy response. The study of the immunological parameters before, during and after treatment is referred to as immunomonitoring. This review discusses the current knowledge of immunomonitoring markers in gastrointestinal cancers. The last decade has seen a collaborative effort to standardize the assays performed in clinical trials to assess response to immunotherapy. Since then, multiple studies have been conducted on blood samples, biopsies and surgical specimens to determine their immunological profiles leading to the identification of several immunological markers possessing a predictive value of response to treatment. Future research will foc...Continue Reading

References

Jul 6, 2002·Critical Reviews in Oncology/hematology·Rong-Fu WangHan Ying
Aug 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Udaya K LiyanageDavid C Linehan
Nov 18, 2004·Immunological Reviews·Mark J SmythYoshihiro Hayakawa
Jun 15, 2007·Tissue Antigens·J I EllyardC R Parish
Aug 28, 2007·Cancer Immunology, Immunotherapy : CII·Sylvia JanetzkiUNKNOWN Elispot Proficiency Panel of the CVC Immune Assay Working Group
Oct 13, 2009·Genome Research·UNKNOWN NIH HMP Working GroupMark Guyer
Jun 8, 2012·Science·Lora V HooperAndrew J Macpherson
Jul 12, 2012·Nature Communications·Sonia FeauStephen P Schoenberger
Dec 18, 2012·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Sine HadrupPer Thor Straten
Sep 10, 2013·Nature Reviews. Immunology·Eric T Ahrens, Jeff W M Bulte
Oct 24, 2013·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·E TohI Botterill
Dec 21, 2013·Science·Jennifer Couzin-Frankel
Jan 21, 2014·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·In Rae ChoYong Chan Lee
Jul 1, 2014·World Journal of Gastroenterology : WJG·Li ZhongMihai Covasa
Oct 21, 2014·European Journal of Immunology·Amiran DzutsevGiorgio Trinchieri
Nov 14, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Faruk TasDerya Duranyildiz
Feb 11, 2015·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Faruk TasDerya Duranyildiz
May 28, 2015·Molecular Carcinogenesis·Mei XuJia Luo
Jun 2, 2015·The New England Journal of Medicine·Dung T LeLuis A Diaz
Jul 19, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·David M BarrettCarl H June
Aug 5, 2015·The Journal of Clinical Investigation·Michele W L TengMark J Smyth
Nov 7, 2015·Science·Marie VétizouLaurence Zitvogel
Mar 17, 2016·Journal for Immunotherapy of Cancer·Paul R KunkOsama E Rahma
May 31, 2016·Current Opinion in Immunology·Jennifer A WargoPadmanee Sharma
Sep 7, 2016·Vaccines·Saskia J A M SantegoetsSjoerd H van der Burg
Nov 1, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kensuke YamamuraHideo Baba
Nov 2, 2016·Expert Opinion on Biological Therapy·Elham Beyranvand NejadSjoerd H van der Burg
Jan 6, 2017·Journal of Clinical Medicine·Nithya KrishnamurthyLaura Nicholson
Jan 12, 2017·Medical Oncology·Jonas CicenasMindaugas Valius

❮ Previous
Next ❯

Citations

Oct 3, 2017·Genes & Cancer·Audrey PlayerWiley Walls

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Nephrology
Rimda WanchooCancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors
Translational Lung Cancer Research
Benjamin A DermanMary J Fidler
American Journal of Respiratory and Critical Care Medicine
Lysanne A LievenseJoachim G Aerts
© 2022 Meta ULC. All rights reserved